Research article2004External
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B
Sandra Hanks, Kim Coleman, Sarah Reid, Alberto Plaja et al.Nature Genetics
Research article2010External
Homozygous BUB1B Mutation and Susceptibility to Gastrointestinal Neoplasia
Thomas Rio Frio, Josée Lavoie, Nancy Hamel, Felipe Correa Geyer et al.New England Journal of Medicine
Research article2015External
Requirement for BUB1B/BUBR1 in tumor progression of lung adenocarcinoma
Honglin Chen, James Lee, Noelyn M. Kljavin, Benjamin Haley et al.Genes & Cancer
Other2020External
BUB1B wt Allele
National Cancer InstituteDefinitions
Research article2017External
The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma
Qing Ma, Yanmei Liu, Liang Shang, Jiao Yu et al.Oncology Reports
Research article2020External
BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway
Jiannan Qiu, Shaopeng Zhang, Peng Wang, Hao Wang et al.Cancer Medicine
Research article2016External
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
Weide Zhong, Xin Fu, Guo Chen, Zhiduan Cai et al.OncoTargets and Therapy
Research article2017External
Sensitivity to BUB1B Inhibition Defines an Alternative Classification of Glioblastoma
Eunjee Lee, Margaret Pain, Huaien Wang, Jacob Herman et al.Cancer Research
Preprint2021External
Differential expression of BUB1B in cancers of the breast.
Shahan Mamoor
Research article2021External
BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability
Xiaozhu Tang, Mengjie Guo, Pinggang Ding, Zhendong Deng et al.Signal Transduction and Targeted Therapy
Research article2026External
BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer
Martinez MJ, Blanco C, Peinetti N, Cooke M et al.Cancer research
Research article2026External
BUB1B is a novel prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma
Tian Z, Jia S, Zheng Q, Hu K et al.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Research article2026External
Functional and clinical evidence for two novel heterozygous <i>BUB1B</i> variants and their value in precision genetic counseling for recurrent pregnancy loss
Wei TY, Kang MX, Zhang GH, Zhang J et al.Frontiers in endocrinology
Research article2026External
Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study
Kabekkodu SP, Rodrigues AF, Hebbar P, Bhat SWorld journal of surgical oncology
Research article2026External
A dual role for miR-210-3p in hypoxia-driven signaling and mitotic regulation in cancer
San-Juan-Guardado J, Turienzo-Durán M, Suárez-Priede Á, Gómez-Suárez N et al.Molecular biomedicine
Research article2026External
Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression
Li P, Shao Y, Wang J, Lin RPeerJ
Research article2026External
In silico discovery of selective TPX2 and BUB1B inhibitors as novel antimitotic agents in breast cancer therapy
Jakkula BK, Perugu SComputational biology and chemistry
Research article2026External
An Integrated Proteomics and Genomics Approach to Identify Essential Protein Kinases During Human Trophoblast Development
Kumar R, Dasgupta P, Ray S, Paul SFASEB journal : official publication of the Federation of American Societies for Experimental Biology
Research article2026External
Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma
Sun CY, Yu X, Deng LQ, Han YJ et al.Scientific reports
Research article2026External
Multi-omics analysis identifies BUB1B as a cell cycle-related driver of bladder cancer progression
Zhou H, Peng S, Ling Z, Cai J et al.World journal of surgical oncology